Ladies and gentlemen, thank you for standing by and welcome to Lufax Holding Limited second quarter 2022 earnings call. Earlier this month, our board approved the resignation of Chairman Ji Guangheng and my appointment as chairman and CEO of Lufax.
The multiple sclerosis market size was valued at USD 25.8 Billion in 2022 and is expected to reach a market size of USD 39.9 Billion by 2032 at a CAGR of 4.6%.Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis. Multiple sclerosis (MS) is a condition characterized by the immune system's assault on the brain and spinal cord. Symptoms vary widely among individuals and hinge on the extent and location of nerve
LONG ISLAND CITY, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Steven Madden, Ltd. (NASDAQ: SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel, today announced that the Company plans to release its first quarter 2024 earnings results on Wednesday, May 1, 2024. Management will host a conference call to review the results at 8:30 a.m. Eastern Time. This call is being webcast live at the Company’s website at https://investor.stevemadden.com or by using the follo
Q3 2024 Lam Research Corp Earnings Call
‘Fusion energy is the ultimate energy source for humanity,’ researchers say
Stock Market Today: Dow Jones futures dived 400 points on GDP data. Meta stock plunged on earnings, while Google and Microsoft report next.
The key Federal Reserve inflation rate, the core PCE price index, reared up in Q1 as GDP grew at a slower pace.
Meta's AI reality check has dented hopes for a Big Tech revival for stocks, with a GDP update waiting in the wings.
A dog walker made the horrific discovery on Tuesday morning
Q1 2024 Western Union Co Earnings Call
Airbus is in talks with China over a potentially major aircraft order ahead of a visit to France by Chinese President Xi Jinping, two people familiar with the matter said. The Chinese leader is due to make his first Europe trip in five years next month and diplomatic sources have said trade will be high on the agenda, amid mounting EU-China tensions. China has historically signalled large jet orders timed to coincide with state visits, but the negotiations between Airbus China's CASC buying agency are expected to go down to the wire and are not guaranteed to result in a deal, the people said.
Q1 2024 JAKKS Pacific Inc Earnings Call
Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. “The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health,” said Vadim Mats, CEO of Gaxos.AI.
The hit comedian and actress gets more candid than ever before about her health ahead of new memoir 'I Curse You With Joy', out May 7
OCALA, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. For the CEO Corner segment, Thomas Equels, Chief Executive Officer of AIM ImmunoTech, gave an overview of Metastatic Pancreatic Cancer and the ongoing Phase 1b/2 clinical trial combining AIM’s Ampligen® (rintatolimod) with AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab
With Over $675,000 Raised, the Gala Benefits the Peter Boyle Research Fund and Celebrates Groundbreaking Myeloma Research, Education, Support, and AdvocacySTUDIO CITY, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- On Thursday, April 18, The International Myeloma Foundation (IMF) held its 15th Annual Gala for the first time at the Edison Ballroom in New York City at 6 p.m. EST. A Media Snippet accompanying this announcement is available by clicking on this link. Hosted by renowned actor and comedian
The Collaboration will Include SKYX’s Advanced and Smart Products to Both Professional and Retail Markets The Collaboration Agreement Provides SKYX Substantial Backing in Several Areas Including Financial, Mass Production Manufacturing Capabilities, and Distribution to Global Markets MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive smart platform technology company with more than 90 issued and p
Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement, employers and other organizations tools to enhance public safetyVANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of alcohol and marijuana breathalyzer screening devices for law enforcement and the workplace reports that Friedel, LLC (“Friedel Clinic”) a private monitoring agency, ba
Trustmark Corporation (NASDAQ:TRMK) Q1 2024 Earnings Call Transcript April 24, 2024 Trustmark Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to Trustmark Corporation’s First Quarter Earnings Conference Call. At this time, all […]
Residents fear the scheme will do nothing to reduce tourist numbers, but will turn Venice into ‘a museum, a theme park’
AbbVie said on Thursday its drug, Rinvoq, for treating a type of inflammatory skin condition was found to be more effective than Regeneron Pharmaceuticals and Sanofi's Dupixent in a late-stage head-to-head study. Rinvoq helped 19.9% of patients simultaneously achieve near-complete skin clearance with a no-to-little itch after 16 weeks of treatment, compared with 8.9% of patients treated with Dupixent, the study showed. The study is the first head-to-head trial in adults and adolescents with moderate-to-severe atopic dermatitis and had shown an inadequate response to systemic therapy, AbbVie said.
Yahoo Finance